# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-22-006637
Filing Date
2022-03-11
Accepted
2022-03-11 16:25:23
Documents
40
Period of Report
2022-03-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 52224
2 |  | ex99-1.htm | EX-99.1 | 24294
3 |  | ex99-1_001.jpg | GRAPHIC | 104382
4 |  | ex99-1_002.jpg | GRAPHIC | 433542
5 |  | ex99-1_003.jpg | GRAPHIC | 179618
6 |  | ex99-1_004.jpg | GRAPHIC | 272510
7 |  | ex99-1_005.jpg | GRAPHIC | 221159
8 |  | ex99-1_006.jpg | GRAPHIC | 149377
9 |  | ex99-1_007.jpg | GRAPHIC | 229819
10 |  | ex99-1_008.jpg | GRAPHIC | 301958
11 |  | ex99-1_009.jpg | GRAPHIC | 78741
12 |  | ex99-1_010.jpg | GRAPHIC | 254366
13 |  | ex99-1_011.jpg | GRAPHIC | 253880
14 |  | ex99-1_012.jpg | GRAPHIC | 350463
15 |  | ex99-1_013.jpg | GRAPHIC | 207078
16 |  | ex99-1_014.jpg | GRAPHIC | 79332
17 |  | ex99-1_015.jpg | GRAPHIC | 265559
18 |  | ex99-1_016.jpg | GRAPHIC | 255771
19 |  | ex99-1_017.jpg | GRAPHIC | 78413
20 |  | ex99-1_018.jpg | GRAPHIC | 230785
21 |  | ex99-1_019.jpg | GRAPHIC | 225815
22 |  | ex99-1_020.jpg | GRAPHIC | 224223
23 |  | ex99-1_021.jpg | GRAPHIC | 315264
24 |  | ex99-1_022.jpg | GRAPHIC | 249624
25 |  | ex99-1_023.jpg | GRAPHIC | 243622
26 |  | ex99-1_024.jpg | GRAPHIC | 76771
27 |  | ex99-1_025.jpg | GRAPHIC | 299686
28 |  | ex99-1_026.jpg | GRAPHIC | 208184
29 |  | ex99-1_027.jpg | GRAPHIC | 166244
| Complete submission text file | 0001493152-22-006637.txt |  | 8454809

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
30 | XBRL SCHEMA FILE | anix-20220310.xsd | EX-101.SCH | 3024
31 | XBRL LABEL FILE | anix-20220310_lab.xml | EX-101.LAB | 34476
32 | XBRL PRESENTATION FILE | anix-20220310_pre.xml | EX-101.PRE | 22589
34 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3623

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 22733469
SIC: 2834 Pharmaceutical Preparations